Skip to main content
. 2019 Feb 20;5(3):e427. doi: 10.1097/TXD.0000000000000866

FIGURE 1.

FIGURE 1

The effect of antiviral treatment era on early graft survival by diagnosis. Panel A depicts the improved graft survival among patients with hepatitis C virus (HCV) with each advancing era (all pairwise log rank P ≤ 0.001). This temporal relationship was not observed in recipients with hepatitis B virus (HBV) (panel B), nonalcoholic steatohepatitis (NASH) (panel C), or alcoholic liver disease (ALD) (panel D). DAA, direct-acting antiviral; IFN, interferon; PI, protease inhibitors.